These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9453427)

  • 1. The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients.
    McCarthy M; Ramage J; McNair A; Gane E; Portmann B; Pagliuca A; Rela M; Heaton N; Mufti GJ; Williams R
    J Hepatol; 1997 Dec; 27(6):1015-21. PubMed ID: 9453427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
    Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ;
    Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus-related localized hepatic lymphoproliferative disorders after liver transplantation.
    Raymond E; Tricottet V; Samuel D; Reynès M; Bismuth H; Misset JL
    Cancer; 1995 Oct; 76(8):1344-51. PubMed ID: 8620407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.
    Ben-Ari Z; Amlot P; Lachmanan SR; Tur-Kaspa R; Rolles K; Burroughs AK
    Liver Transpl Surg; 1999 May; 5(3):184-91. PubMed ID: 10226108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.
    Mamzer-Bruneel MF; Lomé C; Morelon E; Levy V; Bourquelot P; Jacobs F; Gessain A; Mac Intyre E; Brousse N; Kreis H; Hermine O
    J Clin Oncol; 2000 Nov; 18(21):3622-32. PubMed ID: 11054435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplant lymphoma--a single-center experience of 500 liver transplantations.
    Norin S; Kimby E; Ericzon BG; Christensson B; Sander B; Söderdahl G; Hägglund H
    Med Oncol; 2004; 21(3):273-84. PubMed ID: 15456956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-Transplant Lymphoproliferative Disorder (PTLD) Manifesting in the Oral Cavity of a 13-Year-Old Liver Transplant Recipient (LTx).
    Krasuska-Sławińska E; Minko-Chojnowska I; Pawłowska J; Dembowska-Bagińska B; Pronicki M; Olczak-Kowalczyk D
    Ann Transplant; 2015 Aug; 20():478-82. PubMed ID: 26285106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Epstein-Barr virus primary infection in pediatric liver transplant recipients.
    Smets F; Bodeus M; Goubau P; Reding R; Otte JB; Buts JP; Sokal EM
    J Hepatol; 2000 Jan; 32(1):100-4. PubMed ID: 10673073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients.
    Boulanger E; Agbalika F; Maarek O; Daniel MT; Grollet L; Molina JM; Sigaux F; Oksenhendler E
    Hematol J; 2001; 2(3):172-9. PubMed ID: 11920242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
    Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
    Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
    Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
    J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-transplantation lymphoproliferative disorder in childhood].
    Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A
    Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients.
    Strazzabosco M; Corneo B; Iemmolo RM; Menin C; Gerunda G; Bonaldi L; Merenda R; Neri D; Poletti A; Montagna M; Del Mistro A; Faccioli AM; D'Andrea E
    J Hepatol; 1997 Apr; 26(4):926-34. PubMed ID: 9126809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients.
    Milpied N; Vasseur B; Parquet N; Garnier JL; Antoine C; Quartier P; Carret AS; Bouscary D; Faye A; Bourbigot B; Reguerre Y; Stoppa AM; Bourquard P; Hurault de Ligny B; Dubief F; Mathieu-Boue A; Leblond V
    Ann Oncol; 2000; 11 Suppl 1():113-6. PubMed ID: 10707791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases.
    Patel H; Vogl DT; Aqui N; Shaked A; Olthoff K; Markmann J; Reddy R; Stadtmauer EA; Schuster S; Tsai DE
    Leuk Lymphoma; 2007 May; 48(5):885-91. PubMed ID: 17487731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy.
    Garrett TJ; Chadburn A; Barr ML; Drusin RE; Chen JM; Schulman LL; Smith CR; Reison DS; Rose EA; Michler RE
    Cancer; 1993 Nov; 72(9):2782-5. PubMed ID: 8402504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.
    Trappe RU; Dierickx D; Zimmermann H; Morschhauser F; Mollee P; Zaucha JM; Dreyling MH; Dührsen U; Reinke P; Verhoef G; Subklewe M; Hüttmann A; Tousseyn T; Salles G; Kliem V; Hauser IA; Tarella C; Van Den Neste E; Gheysens O; Anagnostopoulos I; Leblond V; Riess H; Choquet S
    J Clin Oncol; 2017 Feb; 35(5):536-543. PubMed ID: 27992268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoproliferative disease of donor origin arising in patients after orthotopic liver transplantation.
    Armes JE; Angus P; Southey MC; Battaglia SE; Ross BC; Jones RM; Venter DJ
    Cancer; 1994 Nov; 74(9):2436-41. PubMed ID: 7922997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.
    McDiarmid SV; Jordan S; Kim GS; Toyoda M; Goss JA; Vargas JH; Martín MG; Bahar R; Maxfield AL; Ament ME; Busuttil RW
    Transplantation; 1998 Dec; 66(12):1604-11. PubMed ID: 9884246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
    Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
    Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.